AB-16B5

· Alethia Biotherapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AB-16B5, covering 2017-06-28 to 2025-04-06. Get the full timeline:

Most recent: Clinical Trial Update: AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002) [Phase 2]